ArticleClinical & experimental metastasis2005

Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.

Cristiana Savorè et al.PubMed ↗Publisher ↗

No numbers read from the abstract.